Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.
Miyashita K, Tomita N, Taguri M, Suzuki T, Ishiyama Y, Ishii Y, Nakajima Y, Numata A, Hattori Y, Yamamoto W, Miyazaki T, Tachibana T, Takasaki H, Matsumoto K, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y.
Miyashita K, et al. Among authors: taguri m.
Leuk Res. 2015 Aug 29:S0145-2126(15)30368-4. doi: 10.1016/j.leukres.2015.08.016. Online ahead of print.
Leuk Res. 2015.
PMID: 26350140